These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24446548)

  • 1. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study.
    Wang L; Li X; Li K; Su Y; Zeng Y; Zhang Q; Wang G; Jin Z; Kong Q; Si T
    Metab Brain Dis; 2017 Feb; 32(1):147-154. PubMed ID: 27524655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.
    Godlewska BR; Browning M; Norbury R; Cowen PJ; Harmer CJ
    Transl Psychiatry; 2016 Nov; 6(11):e957. PubMed ID: 27874847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.
    Leuchter AF; Hunter AM; Jain FA; Tartter M; Crump C; Cook IA
    J Psychiatr Res; 2017 Jan; 84():174-183. PubMed ID: 27770740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amygdala biomarkers of treatment response in major depressive disorder: An fMRI systematic review of SSRI antidepressants.
    Tassone VK; Gholamali Nezhad F; Demchenko I; Rueda A; Bhat V
    Psychiatry Res Neuroimaging; 2024 Mar; 338():111777. PubMed ID: 38183847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy.
    Rosenblau G; Sterzer P; Stoy M; Park S; Friedel E; Heinz A; Pilhatsch M; Bauer M; Ströhle A
    J Psychopharmacol; 2012 Nov; 26(11):1424-33. PubMed ID: 22767373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
    Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
    BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Default mode network deactivation during emotion processing predicts early antidepressant response.
    Spies M; Kraus C; Geissberger N; Auer B; Klöbl M; Tik M; Stürkat IL; Hahn A; Woletz M; Pfabigan DM; Kasper S; Lamm C; Windischberger C; Lanzenberger R
    Transl Psychiatry; 2017 Jan; 7(1):e1008. PubMed ID: 28117844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.
    Vai B; Bulgarelli C; Godlewska BR; Cowen PJ; Benedetti F; Harmer CJ
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):2000-2010. PubMed ID: 27756525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram.
    Stoy M; Schlagenhauf F; Sterzer P; Bermpohl F; Hägele C; Suchotzki K; Schmack K; Wrase J; Ricken R; Knutson B; Adli M; Bauer M; Heinz A; Ströhle A
    J Psychopharmacol; 2012 May; 26(5):677-88. PubMed ID: 21926423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Herrera-Guzmán D; Guàrdia-Olmos J; Hinojosa-Calvo E; Herrera-Abarca JE
    J Psychiatr Res; 2009 Jun; 43(9):855-63. PubMed ID: 19128810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antidepressant treatment on resting-state functional brain networks in patients with major depressive disorder.
    Wang L; Xia M; Li K; Zeng Y; Su Y; Dai W; Zhang Q; Jin Z; Mitchell PB; Yu X; He Y; Si T
    Hum Brain Mapp; 2015 Feb; 36(2):768-78. PubMed ID: 25332057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
    Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
    Trials; 2013 Jul; 14():224. PubMed ID: 23866851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents.
    Lee KH; Shin J; Lee J; Yoo JH; Kim JW; Brent DA
    JAMA Netw Open; 2023 Aug; 6(8):e2327331. PubMed ID: 37540512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics.
    Siegle GJ; Thompson WK; Collier A; Berman SR; Feldmiller J; Thase ME; Friedman ES
    Arch Gen Psychiatry; 2012 Sep; 69(9):913-24. PubMed ID: 22945620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
    Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
    Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.